Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The BUY prediction by BiotechBee finished with a performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | 13.454% | 13.454% | 9.399% | 15.496% |
| iShares Core DAX® | 0.388% | 0.145% | 10.959% | 58.440% |
| iShares Nasdaq 100 | 1.307% | -2.548% | -0.608% | 84.240% |
| iShares Nikkei 225® | -0.463% | 6.891% | 26.748% | 63.400% |
| iShares S&P 500 | 1.314% | -1.163% | -0.036% | 58.216% |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Acadia Pharmaceuticals diskutieren
Buy mit Kursziel 22,0
In the thread Trading Acadia Pharmaceuticals
Buy beendet

